Drug Insights

How to Effectively Search for Nitrofurantoin on Synapse

18 February 2024
2 min read

Nitrofurantoin, an antibiotic medication approved in 1953 by Procter & Gamble, is used to treat uncomplicated lower urinary tract infections.Nitrofurantoin works by using multiple mechanisms to achieve an antimicrobial effect, including uptake by bacterial intracellular flavoproteins and reduction to reactive intermediates that bind to bacterial ribosomes and inhibit DNA and RNA synthesis, cell wall protein synthesis, and other metabolic enzymes. Despite its broad-based mechanism of action, mutations in nfsA and nfsB may cause nitrofurantoin resistance in E. coli. Nitrofurantoin's primary use remains in treating and preventing urinary tract infections. However, common side effects such as nausea, loss of appetite, diarrhea, and headaches may occur. It is important to complete the full course of treatment as prescribed by a healthcare provider to ensure the infection is fully cleared. Click on the image below to begin the exploration journey of Nitrofurantoin through the Synapse database!

图形用户界面, 应用程序, 电子邮件

描述已自动生成

You can search for the latest pharmaceutical information such as drugs, targets, patents, transactions, clinical results, etc. through the Synapse database. Come and experience it!

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Sangamo Therapeutics Unveils Promising Phase 1/2 Results for Fabry Disease Research
Latest Hotspot
3 min read
Sangamo Therapeutics Unveils Promising Phase 1/2 Results for Fabry Disease Research
18 February 2024
Sangamo Therapeutics Reveals New Findings from Phase 1/2 STAAR Research for Fabry Disease Indicating Continuous Efficacy and Unique Safety Data.
Read →
Casdozokitug: A Quick Look at Its R&D Progress and Clinical Results from the 2024 ASCO_GI
Casdozokitug: A Quick Look at Its R&D Progress and Clinical Results from the 2024 ASCO_GI
18 February 2024
Phase 2 results of IL-27, PD-(L)1, VEGF blockade using casdozokitug, atezo, and bev in uHCC patients were presented at 2024 ASCO_GI on Jan 18th.
Read →
CSL & Arcturus' sa-mRNA Technology May Provide Longer Immunity than Standard COVID Boosters
Latest Hotspot
3 min read
CSL & Arcturus' sa-mRNA Technology May Provide Longer Immunity than Standard COVID Boosters
18 February 2024
Findings on CSL and Arcturus' sa-mRNA technology suggest extended immunity compared to standard mRNA COVID booster shots.
Read →
Your Ultimate Guide to Finding Hydrocodone on Synapse
Drug Insights
2 min read
Your Ultimate Guide to Finding Hydrocodone on Synapse
18 February 2024
Hydrocodone bitartrate is a drug commonly used for pain relief, approved first in the United States. The drug works by binding to opioid receptors in the brain, acting as a mu/kappa/delta agonist.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.